 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 01/05/2026 |
$1.82 |
$1.86 |
$1.77 |
$1.80 |
197.40K | | 01/06/2026 |
$1.88 |
$1.94 |
$1.71 |
$1.89 |
1.85M | | 01/07/2026 |
$1.95 |
$2.03 |
$1.79 |
$1.89 |
1.04M | | 01/08/2026 |
$1.80 |
$2.04 |
$1.77 |
$2.00 |
512.30K | | 01/09/2026 |
$2.03 |
$2.59 |
$1.95 |
$2.20 |
3.27M |
|
|
| Genprex, Inc. is a clinical-stage gene therapy company focused on developing therapies for patients with cancer and diabetes. Co.'s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes, who have limited treatment options. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid nanoparticles. Co.'s lead product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). | |
|
Genprex (GNPX) has the following price history information. Looking back at GNPX historical stock prices for the last five trading days, on January 05, 2026, GNPX opened at $1.82, traded as high as $1.86 and as low as $1.77, and closed at $1.80. Trading volume was a total of 197.40K shares. On January 06, 2026, GNPX opened at $1.88, traded as high as $1.94 and as low as $1.71, and closed at $1.89. Trading volume was a total of 1.85M shares. On January 07, 2026, GNPX opened at $1.95, traded as high as $2.03 and as low as $1.79, and closed at $1.89. Trading volume was a total of 1.04M shares. On January 08, 2026, GNPX opened at $1.80, traded as high as $2.04 and as low as $1.77, and closed at $2.00. Trading volume was a total of 512.30K shares. On January 09, 2026, GNPX opened at $2.03, traded as high as $2.59 and as low as $1.95, and closed at $2.20. Trading volume was a total of 3.27M shares.
GNPX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Genprex shares, starting with a $10,000 purchase of GNPX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/02/2018 |
|
| End date: |
01/09/2026 |
|
| Start price/share: |
$9,000.00 |
|
| End price/share: |
$2.20 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-99.98% |
|
| Average Annual Total Return: |
-65.67% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$2.45 |
|
| Years: |
7.78 |
|
|
|
| Date |
Close |
| 01/05/2026 | $1.80 | | 01/06/2026 | $1.89 | | 01/07/2026 | $1.89 | | 01/08/2026 | $2.00 | | 01/09/2026 | $2.20 |
|
|
Free GNPX Email Alerts:
